Alon Maor
Venture Partner @ BRM Capital
Alon Maor is a Series A investor at BRM Capital focused on Medical and Health Care. Alon Maor joined BRM in the summer of 2011. He is responsible for the life science investments, bringing an extensive background in healthcare as a senior executive with over 22 years of experience in the medical device business. Prior to BRM, Alon founded Aesthera Corporation - a Kleiner Perkins backed innovator of light based technologies forskin treatments - in 2004 and served as CEO and Chairman from inception through acquisition by Solta Medical six years later. Prior to founding Aesthera, he served from 2001 - 2003 as Executive Vice President and General Manager of the Aesthetic Business Unit at Lumenis. Between 1999 and 2001, he established ESC's Asia operations and served as the CEO of the Asian Operations growing the business to $38 million. While responsible for Japan and Asia, Alon played a pivotal role in both establishing and growing the Asian market for laser and light based products. Prior to that, Alon spent 10 years at Direx Medical Systems, during which he established Direx Japan as a leading player in diagnostic and therapeutic systems in the Japanese and Asian Urology market.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Alon Maor invests in
Stages Alon Maor invests in
Countries Alon Maor invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kamari Pharma develops innovative treatments for unmet needs and rare diseases in dermatology. | $23M / Series A / Jun 03, 2025 | ||
| their mission is to develop safe and effective neurovascular medical devices that are beneficial to patients and meet physicians' needs. They are committed to advancing patient care by providing the most reliable, easiest to use and highest quality products supported by proven clinical data. Rapid Medical is located at the northern part ofIsrael between the Carmel Mountain and the hills of Ramot Menashe. | $9M / Series B / Jul 17, 2017 |
Co-Investors
About BRM Capital
BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.
BRM Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alon Maor
Venture Partner
|
|||
Arie Nachmias
VP FINANCE & CFO
|
|||
Yuval Rakavy
Founder
|
|||
Eli Barkat
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alon Maor invest in?
Alon Maor invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alon Maor?
Public channels for Alon Maor include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alon Maor last invest?
The most recent investment recorded for Alon Maor closed in Jun 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
